Long COVID also possible after a mild case: interim research results More than 95% of the 1,741 participants in RIVM’s LongCOVID study, who reported long-term symptoms after COVID-19, had mild symptoms during the acute phase of the infection.
Number of positive COVID-19 tests doubled in one week In the past week from 30 June to 6 July 2021, the number of reported positive COVID-19 tests doubled (+103%) compared to the previous week. This increase was observed in all security regions.
Reported COVID-19 infections are still rising, but less rapidly The number of reported COVID-19 infections continued increasing last week. However, the number of newly reported infections once again rose less quickly than in the week before that.
Coronavirus measures: public support remains high, despite concerns With the rapid increase in infections, people estimate their own risk of becoming infected as higher than it was 6 weeks ago (previously 10%, now 18%).
Novel coronavirus continues to spread unabated The number of reported cases of COVID-19 continues to rise in all regions and in all age groups. The Municipal Public Health Service (GGD) reported that 43,903 people tested positive for COVID-19 in the past week.
Initial results of rapid antigen tests for COVID-19 very promising Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.
RIVM presents four scenarios on future public health at European Health Forum Gastein On the first day of the 17th European Health Forum Gastein (EHFG), the Dutch National Institute for Public Health and the Environment (RIVM) organises a workshop on ‘Our health in 2040’.